Lockheed Martin Investment Management’s Novo Nordisk NVO Stock Holding History

Lockheed Martin Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Hold	30,900	–	–	0.06%	117
2026 Q1	$1.14M	Buy	30,900 +2,950	+11%	+$140K	0.04%	108
2025 Q4	$1.42M	Hold	27,950	–	–	0.05%	97
2025 Q3	$1.55M	Sell	27,950 -15,500	-36%	-$907K	0.06%	104
2025 Q2	$3M	Buy	43,450 +27,900	+179%	+$1.9M	0.11%	92
2025 Q1	$1.08M	Sell	15,550 -57,000	-79%	-$4.71M	0.04%	108
2024 Q4	$6.24M	Buy	72,550 +53,800	+287%	+$5.82M	0.25%	66
2024 Q3	$2.23M	Sell	18,750 -11,650	-38%	-$1.55M	0.1%	85
2024 Q2	$4.34M	Sell	30,400 -2,060	-6%	-$273K	0.25%	68
2024 Q1	$4.17M	Sell	32,460 -4,200	-11%	-$500K	0.3%	62
2023 Q4	$3.79M	Buy	+36,660	New	+$3.63M	0.27%	57
2017 Q3	–	Sell	-219,000	Closed	-$4.7M	–	141
2017 Q2	$4.7M	Hold	219,000	–	–	0.26%	58
2017 Q1	$3.75M	Buy	+219,000	New	+$3.81M	0.21%	63

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Lockheed Martin Investment Management's NVO Position: Q2 2026 in Review

Lockheed Martin Investment Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 30,900 shares worth $1.48M. The position accounts for 0.06% of the portfolio, ranked #117.

Lockheed Martin Investment Management first reported a position in NVO in Q1 2017 and has held it in 13 quarters since. The position peaked at $6.24M in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Lockheed Martin Investment Management held 30,900 shares of Novo Nordisk worth $1.48M as of Q2 2026.
Lockheed Martin Investment Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.06% of Lockheed Martin Investment Management's portfolio in Q2 2026, its #117 holding.
Lockheed Martin Investment Management first reported a position in Novo Nordisk in Q1 2017 and has held it in 13 quarters since.
Lockheed Martin Investment Management's Novo Nordisk position peaked at $6.24M in Q4 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.